Director, Bioproducts Research and Development @ Eli Lilly and Company
Director, MIH-TDA, Global Regulatory Affairs, CMC @ Eli Lilly and Company
Senior Advisor, , MIH-TDA, Global Regulatory Affairs, CMC @ Eli Lilly and Company
Senior Advisor, MIH-TDA, Bioassay CMC @ Eli Lilly and Company
Senior Research Scientist, Biotech Discovery Research (BioTDR) @ Eli Lilly and Company
Research Scientist, Biotech Discovery Research (BioTDR) @ Eli Lilly and Company
Post-Doctoral Fellow, Respiratory, Autoimmune and Inflammatory Disorders @ MedImmune
Payal Mehta's Education
The Ohio State University
PhD (Immunology (Ohio State Biochemistry Program))
2004 - 2011
Indian Institute of Technology, Delhi
MS (Chemistry)
2002 - 2004
St. Stephen's College, Delhi
BS (Chemistry (Hons))
1999 - 2002
Payal Mehta's Skills
Autoimmunity
Cell Biology
Signal Transduction
ELISA
Western Blotting
Fc Gamma Receptors
Antigen Presenting Cells
Cell Signaling
Isolation
Confocal Microscopy
Payal Mehta's Summary
Payal Mehta, based in Indianapolis, IN, US, is currently a Director, Bioproducts Research and Development at Eli Lilly and Company, bringing experience from previous roles at Eli Lilly and Company. Payal Mehta holds a 2004 - 2011 PhD in Immunology (Ohio State Biochemistry Program) @ The Ohio State University. With a robust skill set that includes Autoimmunity, Cell Biology, Signal Transduction, ELISA, Western Blotting and more, Payal Mehta contributes valuable insights to the industry. Payal Mehta has 3 emails on RocketReach.